Home Topics Drug Discovery Antibiotics Enhance RNAi Capabilities Antibiotics Enhance RNAi Capabilities July 31, 2008 – Interview with Peng Jin, Ph.D., Assistant Professor, Department of Human Genetics, Emory University School of Medicine /wp-content/uploads/2018/09/gc221_7_31_2008.mp3 PodcastsResourcesAntibioticsCellular, Molecular and Developmental BiologyDrug discoveryDrug research and developmentDrugsMolecular biologyPharmacologyRNA biologyRNA interference Also of Interest Gene Network Interactions Shed Insight into Breast Cancer Onset and Development Bruker to Acquire NanoString with $392.6M Winning Bid At Bio-IT World 2024, AI Applications Take Center Stage Targets for Novel Cancer Immunotherapies Identified by Antibiotics Universal Vaccine Strategy Boosts Body's RNAi Response to Viruses SPARDA: A Programmable Nucleic Acid Targeting Technology Like CRISPR Related Media BIO CEO Rachel King Outlines Industry's Challenges on "Close to the Edge" Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Emerging Markets Collaborate to Succeed in Post-Pandemic World The Sun Sets on AGBT: A Report from the Last Day Spatial, Sequencing, and Sun: A Report from Day 2 of AGBT Related Content Gene Network Interactions Shed Insight into Breast Cancer Onset and Development Bruker to Acquire NanoString with $392.6M Winning Bid At Bio-IT World 2024, AI Applications Take Center Stage Targets for Novel Cancer Immunotherapies Identified by Antibiotics